Therefore, the addition of trehalose as a pharmaceutically acceptable additive for the preparation of a pharmaceutical composition, in particular, in the form of tablets or capsules, is another important aspect of the present invention
The compounds discussed are investigational and, unless otherwise noted, have not been approved for human therapeutic use by Health Canada or any other regulatory body
The immune system peptides guide explores this distinction in detail
No - TB-500 distributes systemically regardless of where you inject
The answer, for a growing number of researchers, is that there is no reason to settle
Injecting can also come with risks like pain and swelling at the injection site, infection or allergic reaction